Name: Roadmap to an IND for mRNA Products: Regulatory Expectations and Potential Roadblocks for Nonclinical, Clinical and CMC
Uploaded: 2022-05-25T19:31:58.419Z

STREAMLY_TIDES-US_LOGO (002).jpg

Back

large_STREAMLY_TIDES-US_BACKGROUND.jpg

medium_STREAMLY_TIDES-US_BACKGROUND.jpg

small_STREAMLY_TIDES-US_BACKGROUND.jpg

thumbnail_STREAMLY_TIDES-US_BACKGROUND.jpg

xlarge_STREAMLY_TIDES-US_BACKGROUND.jpg

xsmall_STREAMLY_TIDES-US_BACKGROUND.jpg

STREAMLY_TIDES-US_BACKGROUND.jpg

New events

Or filter by your interest

Browse all our content

Tides USA 2022

Unlock all the content with only {{price}}

Chris Swenson

Head of Global Regulatory Affairs

large_TIDES-US-thumbnail.jpg

medium_TIDES-US-thumbnail.jpg

small_TIDES-US-thumbnail.jpg

thumbnail_TIDES-US-thumbnail.jpg

xsmall_TIDES-US-thumbnail.jpg

TIDES-US-thumbnail.jpg

Roadmap to an IND for mRNA Products: Regulatory Expectations and Potential Roadblocks for Nonclinical, Clinical and CMC

Workshop AM3: An Introduction to mRNA Technology- ROOM 104